Pds biotech announces abstract accepted for presentation at esmo targeted anticancer therapies congress

Abstract, titled “hpv16-specific cd4 and cd8 t cell activation and functionality in patients receiving combination pds0101 immunotherapy,” highlights data generated from versatile-002 phase 2 study abstract, titled “hpv16-specific cd4 and cd8 t cell activation and functionality in patients receiving combination pds0101 immunotherapy,” highlights data generated from versatile-002 phase 2 study
PDSB Ratings Summary
PDSB Quant Ranking